Rapidly progressive invasive pulmonary aspergillosis in a diabetic man

Yuko Komase1, Hiroyuki Kunishima, Hiromichi Yamaguchi

  • 1Department of Respiratory Internal Medicine, St. Marianna University School of Medicine, Yokohama-city Seibu Hospital, Yokohama, Japan, Yokohama, Kanagawa 241-0811, Japan. yukomase@marianna-u.ac.jp

Insights

This case report details a rare instance of invasive pulmonary aspergillosis in a diabetic man with normal neutrophil function. Despite aggressive treatment, the patient succumbed to respiratory failure, highlighting the challenges in managing this aggressive fungal infection.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Invasive pulmonary aspergillosis (IPA) is a severe fungal infection, often affecting immunocompromised individuals.
  • Neutrophil dysfunction is a known risk factor for invasive fungal infections.

Observation:

  • A 45-year-old diabetic male presented with high fever and productive cough.
  • Chest X-ray revealed bronchobronchiolitis and bronchial thickening.
  • Diagnosis of pulmonary aspergillosis was confirmed via sputum culture, PCR for Aspergillus fumigatus, and mannan antigen testing.

Findings:

  • The patient exhibited normal neutrophil phagocytosis and sterilizing functions.
  • Despite treatment with itraconazole, amphotericin B, and meropenem, the patient experienced rapid disease progression.
  • Chest X-ray showed extensive invasive shadows and cavitation, leading to respiratory failure and death.

Implications:

  • This case highlights a rare presentation of IPA in a diabetic patient with preserved neutrophil immunity.
  • It underscores the potential for severe invasive aspergillosis even with seemingly normal immune responses.
  • Further research into risk factors and treatment strategies for IPA in specific patient populations is warranted.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...